**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 7782-64-1 |Manganese(II) fluoride | 99 | 231-960-0 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.Hygroscopic (absorbs
moisture from the air).
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. Ingestion of large amounts of fluoride may cause
salivation, nausea, vomiting, abdominal pain, fever, labored
breathing. Inorganic fluorides can be harmful. Acute exposure to
fluorine compounds can lead to digestive tract burns, and abdominal
pain. Exposure to fluoride compounds can result in systemic toxic
effects on the heart, liver, and kidneys. It may also deplete
calcium levels in the body leading to hypocalcemia and death. In high
doses, manganese may increase anemia by interfering with iron
absorption. Although they are poorly absorbed through the intestine,
inorganic manganese salts may produce hypoglycemia and decreased
calcium blood levels should absorption occur.
Inhalation:
Causes respiratory tract irritation. The lowest exposure
concentration of manganese at which early effects on the CNS and the
lungs may occur is still unknown. However, once neurological signs
are present, they tend to continue and worsen after exposure ends.
Chronic:
Chronic inhalation and ingestion may cause chronic fluoride
poisoning (fluorosis) characterized by weight loss, weakness,
anemia, brittle bones, and stiff joints. Effects may be delayed.
Chronic inhalation or ingestion may result in manganism characterized
by neurological symptoms such as headache, apathy, and weakness of
the legs, followed by psychosis and neurological symptoms similar to
those of Parkinson's disease. Chronic exposure to fluoride compounds
may cause systemic toxicity. May impair fertility. Other chronic
effects from inhaling high amounts of manganese include an increased
incidence of cough and bronchitis and susceptibility to infectious
lung disease.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Substance is noncombustible.
Extinguishing Media:
Use extinguishing media most appropriate for the surrounding fire.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Avoid generating dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Avoid contact with eyes, skin, and
clothing. Keep container tightly closed. Avoid breathing dust.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Store
protected from moisture.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use process enclosure, local exhaust ventilation, or other
engineering controls to control airborne levels below recommended
exposure limits. Facilities storing or utilizing this material should
be equipped with an eyewash facility and a safety shower.
Exposure Limits
CAS# 7782-64-1:
United Kingdom, WEL - TWA: (listed as manganese, inorganic
compounds): 0.5 mg/m3 TWA
United Kingdom, WEL - STEL: (listed as manganese, inorganic
compounds): 1.5 mg/m3 STEL
United States OSHA: 5 mg/m3 Ceiling (as Mn) (listed under Mangan
compounds, n.o.s.).
Belgium - TWA: (listed as manganese compounds, n.o.s.): 0.2 mg/m3
(as Mn)
Japan: (listed as manganese compounds, n.o.s.): 0.3 mg/m3 OEL (ex
organic compounds, as Mn)
Malaysia: (listed as manganese, inorganic compounds): 0.2 mg/m3 T
(as Mn)
Netherlands: (listed as manganese compounds, n.o.s.): 3 mg/m3 STE
(as Mn)
Netherlands: (listed as manganese compounds, n.o.s.): 1 mg/m3 MAC
Mn)
Spain: (listed as manganese, inorganic compounds): 0.2 mg/m3 VLA-
(as Mn)
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: pink
Odor: none reported
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 856 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Insoluble.
Specific Gravity/Density: 3.980
Molecular Formula: F2Mn
Molecular Weight: 92.94
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Dust generation, moisture.
Incompatibilities with Other Materials:
Strong bases.
Hazardous Decomposition Products:
Hydrogen fluoride gas, oxides of manganese.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 7782-64-1: OP0875000
LD50/LC50:
Not available.
Carcinogenicity:
Manganese(II) fluoride -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC SOLID, INORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 3265
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, INORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 3265
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, INORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 3265
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 7782-64-1: No information available.
Canada
CAS# 7782-64-1 is listed on Canada's NDSL List.
CAS# 7782-64-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7782-64-1 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 1/13/2000 Revision #6 Date: 9/03/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|